Here is something to ponder in case you have the jitters.
What is the ONLY difference between the Aussie trials and the USA trials?
Same app.
Same improved processes.
Same dynamic in subject inclusion/exclusion.
Not much difference except the country it is taking place in.
Now unless through some miracle of the creator or however us humans got here, that people in the USA and Australia have different coughs, then you would have to expect that the USA results would mirror the Aussie results we have already been given.
So really...the only chance of a fail here is based in genetics, and that is a finite science that will probably say that there is absolutely no possible way that the coughs are different country to country.
So its time to relax safe in this knowledge.
Everything else you can think of is just time wasting because its a worry that shouldn't exist.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides Update on SMARTCOUGH-C-2 Study Timing
Ann: ResApp Provides Update on SMARTCOUGH-C-2 Study Timing, page-19
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 157 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online